Dawn Odom

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter

Filter by Year

Search Results

Burden and impact of reactogenicity among adults receiving COVID-19 vaccines in the United States and Canada: Results from a prospective observational study

Health-related quality-of-life of patients treated with repotrectinib for neurotrophic tyrosine receptor kinase (NTRK)-positive advanced solid tumors: Results from TRIDENT-1

Patient preferences for tumor-agnostic therapies: Qualitative insights and challenges

Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study

Patient reported outcomes (pro) from ongoing phase 2 registrational trial of repotrectinib in patients with ros1-positive advanced or metastatic non-small cell lung cancer (TRIDENT-1)

Quality of life in primary open-angle glaucoma and cataract: An analysis of VFQ-25 and OSDI from the iStent inject® pivotal trial

Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial

Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types

A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application

The effect of neutropenia on patientreported functioning and quality of life (QOL) among palbociclib participants of the MADELINE study

Benefits and challenges of mobile health applications in prospective studies: Learnings from the Madeline study and literature

Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial

Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (PTS) with nonmetastatic castrate-resistant prostate cancer (NMCRPC) (#249)

Effect of iStent inject trabecular micro-bypass on patient-reported outcomes for those with open-angle glaucoma and coexisting cataracts

Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer: Data from the Madeline study

Effect of regorafenib in delaying definitive deterioration in health-related quality of life across three tumor types

Impact of darolutamide (DARO) on pain and quality of life (QoL) in patients (Pts) with nonmetastatic castrate-resistant prostate cancer (nmCRPC)

Longitudinal modeling approaches to assess the association between changes in 2 clinical outcome assessments

An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability

Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe